|
Volumn 52, Issue 3, 2008, Pages 831-836
|
Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AGAR;
BACTERIAL PROTEIN;
DAPTOMYCIN;
MPRF PROTEIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
YYCG PROTEIN;
ARTICLE;
BACTERIAL ENDOCARDITIS;
BACTERICIDAL ACTIVITY;
BACTERIUM ISOLATE;
CONTROLLED STUDY;
DRUG ACTIVITY;
ENDOCARDITIS;
GENE MUTATION;
HUMAN;
IN VITRO STUDY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
SIMULATION;
STAPHYLOCOCCUS AUREUS;
ANTI-BACTERIAL AGENTS;
CULTURE MEDIA;
DAPTOMYCIN;
DRUG THERAPY, COMBINATION;
ENDOCARDITIS, BACTERIAL;
HUMANS;
METHICILLIN;
METHICILLIN RESISTANCE;
MICROBIAL SENSITIVITY TESTS;
MODELS, BIOLOGICAL;
STAPHYLOCOCCUS AUREUS;
VANCOMYCIN;
|
EID: 40549101845
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.00869-07 Document Type: Article |
Times cited : (80)
|
References (31)
|